Previous 10 | Next 10 |
home / stock / bvaxf / bvaxf news
Vancouver, British Columbia and San Cristóbal de La Laguna, Tenerife, Spain – September 8, 2021 – BioVaxys Technology Corp. (CSE: BIOV) (FRA:5LB) (OTCQB:BVAXF) ( “BioVaxys” or “the Company”) is pleased to announce ...
Further Study in humans shows that the DTH response, the basis for CoviDTH, is highly durable and persists for at least one year after COVID-19 exposure or vaccine administration Canada NewsWire VANCOUVER, BC and SAN CRISTÓBAL DE LA LAGUNA, Spain , Sept. 7...
Clinical Trial Affirms CoviDTH Diagnostic Approach to screen for T cell-mediated immune response to SARS-CoV-2 is safe and effective in humans Canada NewsWire Yvelise Barrios , MD, P hD , Immunologist and leading expert in the clinical use of delayed ty...
BioVaxys Closes Final Tranche Of Non-Brokered Private Placement Canada NewsWire VANCOUVER, BC , July 28, 2021 /CNW/ -- BioVaxys Technology Corp. ( CSE: BIOV, FRA:5LB, OTCQB:BVAXF) ( "BioVaxys" or the " Company ") is pleased to announce that it ha...
FN Media Group Presents USA News Group News Commentary Vancouver, BC – July 22, 2021 – USA News Group – Two of the world’s most prominent billionaires, George Soros and Bill Gates, recently made headlines backing a consortium to buy UK C...
BioVaxys Technology ([[BVAXF]]) announces that the U.S. FDA has provided its official written response to the company's request for a Pre-IND Type B review of CoviDTH as a diagnostic for evaluating T-cell immune response to SARS-CoV-2.The FDA found the chemistry, manufacturing and contro...
Palm Beach, FL – July 22, 2021 – According to WebMD, this week the nation’s top health officials said Tuesday that the Delta variant of the coronavirus is racing through North America and other parts of the world and now is responsible for 83% of all U...
FDA Provides Necessary Guidance For BioVaxys To Begin Preparation Of Ind For Phase I/II Clinical Trials Of CoviDTH Canada NewsWire VANCOUVER, British Columbia , July 22, 2021 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA:5LB) (OTCQB: BVAXF) ( "B...
BioVaxys Closes First Tranche Of Non-brokered Private Placement Canada NewsWire VANCOUVER, British Columbia , July 14, 2021 /CNW/ -- BioVaxys Technology Corp. ( CSE: BIOV, FRA:5LB, OTCQB: BVAXF) ( "BioVaxys" or the "Company") is pleased to announc...
BioVaxys Announces Non-Brokered Private Placement Canada NewsWire VANCOUVER, BC , June 28, 2021 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV, FRA:5LB, OTCQB:BVAXF) ("BioVaxys" or the "Company") is pleased to announce a non-brokered private placement (the "Privat...
News, Short Squeeze, Breakout and More Instantly...
Biondvax Pharms Ltd Ord Company Name:
BVAXF Stock Symbol:
OTCMKTS Market:
Biondvax Pharms Ltd Ord Website:
BIOVAXYS ANNOUNCES PLANNED PRIVATE PLACEMENT AND DEBT SETTLEMENT Canada NewsWire VANCOUVER, BC , July 23, 2024 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (" BioVaxys " or the " Company ") announ...
BIOVAXYS ANNOUNCES ISSUANCE OF DPX RELATED PATENT FROM THE U.S. PATENT AND TRADEMARK OFFICE Canada NewsWire VANCOUVER, BC , July 23, 2024 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") announced that the United ...
Brittany Davison, CPA, CA, Joins BioVaxys as Business Advisor Canada NewsWire VANCOUVER, BC , July 18, 2024 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the "Company") is pleased to announce that it has engaged Brittany Davison , ...